Methods of Paraclinic Diagnosis of Catecholamine Secreting Tumours, Especially of Pheochromocytoma

1. Fliedner SMJ, Brabant G, Lehnert H. Pheochromocytoma and paraganglioma: genotype versus anatomic location as determinants of tumor phenotype. Cell Tissue Res. 2018 Jan 24. doi: 10.1007/s00441-017-2760-3.10.1007/s00441-017-2760-329362886Open DOISearch in Google Scholar

2. Constantin Dumitrache. Endocrinologie clinica. Editura Naţional, 2012. pag 533-534.Search in Google Scholar

3. Zuber SM, Kantorovich V, Pacak K. Hypertension in pheochromocytoma: characteristics and treatment. Endocrinol Metab Clin North Am. 2011;40(2):295-311.10.1016/j.ecl.2011.02.002309454221565668Open DOISearch in Google Scholar

4. Bausch B, Tischler AS, Schmid KW et al. Max Schottelius: Pioneer in Pheochromocytoma. J Endocr Soc. 2017;1(7):957-964.10.1210/js.2017-00208568915029264546Search in Google Scholar

5. Zbranca E. Ghid de diagnostic şi tratament în bolile endocrine, Ed. a III-a, Editura Polirom, 2008.Search in Google Scholar

6. PDQ Adult Treatment Editorial Board. Pheochromocytoma and Paraganglioma Treatment (PDQ^®): Health Professional Version. 2018 Feb 8. In: PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US); 2002.Search in Google Scholar

7. Lenders JWM, Eisenhofer G. Update on Modern Management of Pheochromocytoma and Paraganglioma. Endocrinol Metab (Seoul). 2017;32(2):152-161.10.3803/EnM.2017.32.2.152550385928685506Open DOISearch in Google Scholar

8. Van Berkel A, Lenders JW, Timmers HJ. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma. Eur J Endocrinol. 2014;170(3):R109-19.10.1530/EJE-13-088224347425Search in Google Scholar

9. Raber W, Raffesberg W, Bischof M et al. Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Arch Intern Med. 2000;160(19):2957-63.10.1001/archinte.160.19.295711041903Search in Google Scholar

10. Lenders JW, Pacak K, Walther MM et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287(11):1427-34.10.1001/jama.287.11.142711903030Search in Google Scholar

11. Grouzmann E, Drouard-Troalen L, Baudin E et al. Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma. Eur J Endocrinol. 2010;162(5):951-60.10.1530/EJE-09-099620142367Search in Google Scholar

12. Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92(11):4069-79.10.1210/jc.2007-172017989126Open DOISearch in Google Scholar

13. Zuber S,Wesley R, Prodanov T et al. Clinical utility of chromogranin A in SDHx-related paragangliomas. Eur J Clin Invest. 2014;44(4):365-71.10.1111/eci.1224524467715Open DOISearch in Google Scholar

14. Eisenhofer G, Goldstein DS, Walther MM et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true-from false-positive test results. J Clin Endocrinol Metab. 2003;88(6):2656-66.10.1210/jc.2002-03000512788870Open DOISearch in Google Scholar

15. Ergin AB, Kennedy L, Hamrahian AH, Gupta M. The Cleveland Clinic Manual of Dynamic Endocrine Testing. Clonidine Suppression Test, 2015, pag 55-58.10.1007/978-3-319-13048-4_14Search in Google Scholar

16. Eisenhofer G, Lenders JW, Siegert G et al. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer. 2012;48(11):1739-49.10.1016/j.ejca.2011.07.016337262422036874Search in Google Scholar

17. Osinga TE, Xekouki P, Nambuba J et al. SDH Subunit Mutation Status in Saliva: Genetic Testing in Patients with Pheochromocytoma. Horm Metab Res. 2016;48(4):247-50.10.1055/s-0035-156926526916530Search in Google Scholar

18. Taïeb D, Pacak K. Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma. Cell Tissue Res. 2018. doi: 10.1007/s00441-018-2791-94.10.1007/s00441-018-2791-94Open DOISearch in Google Scholar

19. Willatt J, Chong S, Ruma JA, Kuriakose J. Incidental Adrenal Nodules and Masses: The Imaging Approach. Int J Endocrinol. 2015;2015:410185.10.1155/2015/410185442919526064109Search in Google Scholar

20. Yeomans H, Calissendorff J, Volpe C, Falhammar H, Mannheimer B. Limited value of long-term biochemical follow-up in patients with adrenal incidentalomas-a retrospective cohort study. BMC Endocr Disord. 2015;15:6.10.1186/s12902-015-0001-x437705325887139Search in Google Scholar

21. Santhanam P, Treglia G, Ahima RS. Detection of brown adipose tissue by 18 F-FDG PET/CT in pheochromocytoma/paraganglioma: A systematic review. J Clin Hypertens (Greenwich). 2018. doi: 10.1111/jch.13228.10.1111/jch.13228803080529443440Open DOISearch in Google Scholar